Saliva as a diagnostic specimen for testing respiratory virus by a point-of-care molecular assay: a diagnostic validity study
Kelvin Kai‐Wang To(Hong Kong Science and Technology Parks Corporation), Kwok‐Yung Yuen(University of Hong Kong - Shenzhen Hospital), Alexander Ng(University of Hong Kong), Vincent Chi‐Chung Cheng(Queen Mary Hospital), K.-H. Chan(University of Hong Kong), Carlos King Ho Wong(University of Leicester), Deborah Ho(University of Hong Kong), Cyril Chik‐Yan Yip(Queen Mary Hospital), Kit-Hang Leung(University of Hong Kong), Chuan-Tsai Lai(Queen Mary Hospital), Rosana Wing‐Shan Poon(University of Hong Kong), Ivan Fan‐Ngai Hung(Chinese University of Hong Kong)
Cited by 229
Related Papers
A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster
|The Lancet|2020|9.6k
Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study
|The Lancet Infectious Diseases|2020|3.4k
Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan
|Emerging Microbes & Infections|2020|3.3k
Consistent Detection of 2019 Novel Coronavirus in Saliva
|Clinical Infectious Diseases|2020|2k
Coronaviruses — drug discovery and therapeutic options
|Nature Reviews Drug Discovery|2016|1.8k